A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes

Carine Beysen; Elizabeth J. Murphy; H. N. Nagaraja; Martin Decaris; Timothy Riiff; Alex Fong; Marc Hellerstein; Patrick J. Boyle

doi:10.1194/jlr.m800165-jlr200

Related publications

Article2020

Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies

Fumiaki Imamura, Amanda M. Fretts, Matti Marklund, Andres V Ardisson Korat, Wei-Sin Yang, Maria Lankinen, Waqas Qureshi, Catherine Helmer, Tzu-An Chen, Jyrki K. Virtanen, Kerry LM Wong, Julie K. Bassett, Rachel A. Murphy, Nathan Tintle, Chaoyu Ian Yu, Ingeborg A. Brouwer, Kuo‐Liong Chien, Yun‐Yu Chen, Alexis C. Wood, Liana C. Del Gobbo, Luc Djoussé, Johanna M. Geleijnse, Graham G. Giles, Janette de Goede, Vilmundur Guðnason, William S. Harris, Allison Hodge, Frank B Hu, Albert Koulman, Markku Laakso, Lars Lind, Hung-Ju Lin, Barbara McKnight, Kalina Rajaobelina, Ulf Risérus, Jennifer G. Robinson, Cécilia Samieri, Mackenzie K. Senn, David S. Siscovick, Sabita S Soedamah-Muthu, Nona Sotoodehnia, Qi Sun, Michael Y. Tsai, Tomi‐Pekka Tuomainen, Matti Uusitupa, Lynne E. Wagenknecht, Nicholas J. Wareham, Jason Wu, Renata Micha, Rozenn N. Lemaître, Dariush Mozaffarian, Nita G. Forouhi

Article1996

A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes

Discussion(0)

Related publications

Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies

Regulation of Hepatic De Novo Lipogenesis in Humans

Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans

Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

The contribution of de novo lipogenesis to lipid synthesis in sebum in healthy volunteers